Personal information

Other IDs

Scopus Author ID: 12779561100

Countries

Italy

Activities

Collapse all

Employment (3)

IRCCS Humanitas Research Hospital Department of Gastroenterology: Rozzano, Lombardia, IT

2017-09-04 to present
Employment
Source: Self-asserted source
Alessio Aghemo

Humanitas University: Rozzano, IT

2017-09-04 to present (Department of Biomedical Sciences)
Employment
Source: Self-asserted source
Alessio Aghemo

Ospedale Maggiore Policlinico: Milano, Lombardia, IT

2007-06-04 to 2017-07-31
Employment
Source: Self-asserted source
Alessio Aghemo

Works (50 of 126)

Items per page:
Page 1 of 3

Drug–Drug Interactions Between DAAs and Anticoagulants or Antiplatelets: A Position Paper of the Italian Anticoagulation Clinics

Liver International
2025-02 | Journal article
DOI: 10.1111/liv.16177
Contributors: Elisabetta Tombolini; Alessandro Squizzato; Gian Marco Podda; Alessio Aghemo; Nicola Ferri; Simone Segato; Daniela Poli; Marco Paolo Donadini
Source: check_circle
Crossref

Prevalence of HCV infection in Europe in the DAA era: Review

Liver International
2024-07 | Journal article
DOI: 10.1111/liv.15981
Contributors: Roberta D'Ambrosio; Maria P. Anolli; Nicola Pugliese; Chiara Masetti; Alessio Aghemo; Pietro Lampertico
Source: check_circle
Crossref

The first MASH drug therapy on the horizon: Current perspectives of resmetirom

Liver International
2024-07 | Journal article
DOI: 10.1111/liv.15930
Contributors: Salvatore Petta; Giovanni Targher; Stefano Romeo; Utpal B. Pajvani; Ming‐Hua Zheng; Alessio Aghemo; Luca V. C. Valenti
Source: check_circle
Crossref

Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology
2024-04 | Journal article
DOI: 10.1016/j.cgh.2023.08.033
Contributors: Nicola Pugliese; Vincent Wai-Sun Wong; Jörn M. Schattenberg; Manuel Romero-Gomez; Giada Sebastiani; Alessio Aghemo; Laurent Castera; Cesare Hassan; Pinelopi Manousou; Luca Miele et al.
Source: check_circle
Crossref

Forecasting the long‐term impact of COVID‐19 on hepatitis C elimination plans in Italy: A mathematical modelling approach

Liver International
2023-12 | Journal article
DOI: 10.1111/liv.15712
Contributors: Loreta A. Kondili; Massimo Andreoni; Alessio Aghemo; Claudio Maria Mastroianni; Rocco Merolla; Valentina Gallinaro; Gianpiero D'Offizi; Antonio Craxì
Source: check_circle
Crossref

SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19

Current Medicinal Chemistry
2023-12 | Journal article
DOI: 10.2174/0929867330666230330092725
Contributors: Ligen Yu; Mohd Khanapi Abd Ghani; Alessio Aghemo; Debmalya Barh; Matteo Bassetti; Fausto Catena; Gaetano Gallo; Ali Gholamrezanezhad; Mohammad Amjad Kamal; Amos Lal et al.
Source: check_circle
Crossref

Measuring the impact of the updated Steatotic liver disease nomenclature and definition

Liver International
2023-11 | Journal article
DOI: 10.1111/liv.15731
Contributors: Luca Valenti; Alessio Aghemo; Alejandro Forner; Salvatore Petta; Stefano Romeo; Pierre Nahon
Source: check_circle
Crossref

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International

Liver International
2023-05 | Journal article
DOI: 10.1111/liv.15580
Contributors: Alessio Aghemo; Alejandro Forner; Luca Valenti
Source: check_circle
Crossref

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study

PLOS ONE
2023-02-02 | Journal article
DOI: 10.1371/journal.pone.0280165
Contributors: Alessio Aghemo; Umberto Vespasiani-Gentilucci; Marcello Persico; Roberta D’Ambrosio; Massimo Andreoni; Erica Villa; Abhi Bhagat; Valentina Gallinaro; Giuliana Gualberti; Rocco Cosimo Damiano Merolla et al.
Source: check_circle
Crossref

Clinical features and management issues of NAFLD-related HCC: what we know so far

Expert Review of Gastroenterology & Hepatology
2023-01-02 | Journal article
DOI: 10.1080/17474124.2023.2162503
Contributors: Nicola Pugliese; Ludovico Alfarone; Ivan Arcari; Silvia Giugliano; Tommaso Lorenzo Parigi; Maria Rescigno; Ana Lleo; Alessio Aghemo
Source: check_circle
Crossref

Liver biopsy is associated with increased body weight loss in patients with non‐alcoholic steatohepatitis

Liver International
2022-12 | Journal article
DOI: 10.1111/liv.15420
Contributors: Gianluca Franchellucci; Maria Terrin; Alessio Aghemo; Nicola Pugliese
Source: check_circle
Crossref

No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single‐centre in Milan

Liver International
2022-11 | Journal article
DOI: 10.1111/liv.15400
Contributors: Chiara Masetti; Francesca Colapietro; Antonio Voza; Alessio Aghemo
Source: check_circle
Crossref

No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan

Liver International
2022-09-14 | Journal article
DOI: 10.1111/liv.15407
Contributors: Chiara Masetti; Francesca Colapietro; Antonio Voza; Alessio Aghemo
Source: check_circle
Crossref

High prevalence of porto‐sinusoidal vascular disease in patients with constantly elevated gamma‐glutamyl transferase levels

Liver International
2022-07 | Journal article
DOI: 10.1111/liv.15257
Contributors: Nicola Pugliese; Luca di Tommaso; Ana Lleo; Ludovico Alfarone; Elisabetta Mastrorocco; Maria Terrin; Roberto Ceriani; Francesca Colapietro; Luigi Terracciano; Alessio Aghemo
Source: check_circle
Crossref

Is there an ‘ideal’ diet for patients with NAFLD?

European Journal of Clinical Investigation
2022-03 | Journal article
DOI: 10.1111/eci.13659
Contributors: Nicola Pugliese; Maria Corina Plaz Torres; Salvatore Petta; Luca Valenti; Edoardo G. Giannini; Alessio Aghemo
Source: check_circle
Crossref

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation

Liver International
2022-01 | Journal article
DOI: 10.1111/liv.15070
Contributors: Andrea Marcellusi; Francesco Saverio Mennini; Murad Ruf; Claudio Galli; Alessio Aghemo; Maurizia R. Brunetto; Sergio Babudieri; Antonio Craxi; Massimo Andreoni; Loreta A. Kondili
Source: check_circle
Crossref

Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations

Techniques and Innovations in Gastrointestinal Endoscopy
2021 | Journal article
DOI: 10.1016/j.tige.2021.01.006
Contributors: Edoardo Vespa; Nicola Pugliese; Francesca Colapietro; Alessio Aghemo
Source: check_circle
Crossref

COVID‐19 and the liver: A 2021 update

Liver International
2021-09 | Journal article
DOI: 10.1111/liv.14984
Contributors: Catherine W. Spearman; Alessio Aghemo; Luca Valenti; Mark W. Sonderup
Source: check_circle
Crossref

Management of liver disease in Italy after one year of the SARS‐CoV‐2 pandemic: A web‐based survey

Liver International
2021-09 | Journal article
DOI: 10.1111/liv.14998
Contributors: Francesca Romana Ponziani; Alessio Aghemo; Giuseppe Cabibbo; Mario Masarone; Sara Montagnese; Salvatore Petta; Francesco Paolo Russo; Quirino Lai
Source: check_circle
Crossref

Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study

European Journal of Nuclear Medicine and Molecular Imaging
2021-09-07 | Journal article
DOI: 10.1007/s00259-021-05294-3
Contributors: Martina Sollini; Silvia Morbelli; Michele Ciccarelli; Maurizio Cecconi; Alessio Aghemo; Paola Morelli; Silvia Chiola; Fabrizia Gelardi; Arturo Chiti
Source: check_circle
Crossref

High prevalence of multidrug‐resistant bacteria in patients with pyogenic liver abscess following liver cancer loco‐regional treatments

Liver International
2021-08 | Journal article
DOI: 10.1111/liv.14933
Contributors: Francesca Colapietro; Chiara Masetti; Roberto Ceriani; Paola Morelli; Dario Poretti; Vittorio Pedicini; Nicola Pugliese; Antonio Voza; Ana Lleo; Alessio Aghemo
Source: check_circle
Crossref

Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction

Liver International
2021-07 | Journal article
DOI: 10.1111/liv.14967
Contributors: Chiara Masetti; Alessio Aghemo
Source: check_circle
Crossref

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

Liver International
2021-06 | Journal article
DOI: 10.1111/liv.14825
Contributors: Jörn M. Schattenberg; Jeffrey V. Lazarus; Philip N. Newsome; Lawrence Serfaty; Alessio Aghemo; Salvador Augustin; Emmanuel Tsochatzis; Victor de Ledinghen; Elisabetta Bugianesi; Manuel Romero‐Gomez et al.
Source: check_circle
Crossref

Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study

European Journal of Nuclear Medicine and Molecular Imaging
2021-05-30 | Journal article
DOI: 10.1007/s00259-020-05084-3
Contributors: Martina Sollini; Michele Ciccarelli; Maurizio Cecconi; Alessio Aghemo; Paola Morelli; Fabrizia Gelardi; Arturo Chiti
Source: check_circle
Crossref

Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements

Liver International
2021-04 | Journal article
DOI: 10.1111/liv.14796
Contributors: Loreta A. Kondili; Antonio Craxì; Alessio Aghemo
Source: check_circle
Crossref

Sofosbuvir in HCV patients with chronic kidney disease: No time for caution

Liver International
2021-04 | Journal article
DOI: 10.1111/liv.14845
Contributors: Virginia Solitano; Alessio Aghemo
Source: check_circle
Crossref

Impact of COVID-19 on global HCV elimination efforts

Journal of Hepatology
2021-01 | Journal article
DOI: 10.1016/j.jhep.2020.07.042
Contributors: Sarah Blach; Loreta A. Kondili; Alessio Aghemo; Zongzhen Cai; Ellen Dugan; Chris Estes; Ivane Gamkrelidze; Siya Ma; Jean-Michel Pawlotsky; Devin Razavi-Shearer et al.
Source: check_circle
Crossref

Liver tests abnormalities in COVID-19: trick or treat?

Journal of Hepatology
2020-11 | Journal article
DOI: 10.1016/j.jhep.2020.05.033
Contributors: Edoardo Vespa; Nicola Pugliese; Daniele Piovani; Antonio Capogreco; Silvio Danese; Alessio Aghemo
Source: check_circle
Crossref

Sarcopenia in chronic liver disease: easy to diagnose but hard to treat

Liver International
2020-11 | Journal article
DOI: 10.1111/liv.14690
Contributors: Nicola Pugliese; Ezio Lanza; Alessio Aghemo
Source: check_circle
Crossref

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy

Clinical Gastroenterology and Hepatology
2020-09 | Journal article
DOI: 10.1016/j.cgh.2020.05.011
Contributors: Alessio Aghemo; Daniele Piovani; Tommaso Lorenzo Parigi; Enrico Brunetta; Nicola Pugliese; Edoardo Vespa; Paolo Dario Omodei; Paoletta Preatoni; Ana Lleo; Alessandro Repici et al.
Source: check_circle
Crossref

Postsustained Virological Response Management in Hepatitis C Patients

Seminars in Liver Disease
2020-08-27 | Journal article
DOI: 10.1055/s-0040-1702944
Contributors: Chiara Masetti; Ana Lleo; Matteo Colombo; Massimo Colombo; Alessio Aghemo
Source: check_circle
Crossref

HCV screening: Moving from theory to practice

Liver International
2020-07 | Journal article
DOI: 10.1111/liv.14515
Contributors: Tommaso Lorenzo Parigi; Alessio Aghemo
Source: check_circle
Crossref

Management of patients with autoimmune liver disease during COVID-19 pandemic

Journal of Hepatology
2020-04 | Journal article
DOI: 10.1016/j.jhep.2020.04.002
Contributors: Ana Lleo; Pietro Invernizzi; Ansgar W. Lohse; Alessio Aghemo; Marco Carbone
Source: check_circle
Crossref

Do gamma‐glutamyltransferase levels identify HCV patients who require lifelong post‐SVR follow‐up?

Liver International
2020-03 | Journal article
DOI: 10.1111/liv.14394
Contributors: Francesca Colapietro; Alessio Aghemo
Source: check_circle
Crossref

All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis

Clinical Gastroenterology and Hepatology
2020-01 | Journal article
DOI: 10.1016/j.cgh.2019.07.020
Contributors: Giulia Roda; Ana Lleo; Silvio Danese; Alessio Aghemo
Source: check_circle
Crossref

Editorial: should we abandon HCV genotype testing? Maybe

Alimentary Pharmacology & Therapeutics
2019-04 | Journal article
DOI: 10.1111/apt.15194
Contributors: Maria Corina Plaz Torres; Alessio Aghemo
Source: check_circle
Crossref

High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma

Alimentary Pharmacology & Therapeutics
2018-06 | Journal article
DOI: 10.1111/apt.14685
Contributors: M. Persico; A. Aglitti; A. Aghemo; M. Rendina; A. Lleo; A. Ciancio; V. Di Marco; P. Lampertico; M. R. Brunetto; M. Zuin et al.
Source: check_circle
Crossref

Acute tubular necrosis following interferon-based therapy for hepatitis C: Case study with literature review

2014 | Journal article
DOI:

10.1159/000355753

EID:

2-s2.0-84895709286
Contributors: Fabrizi, F.; Aghemo, A.; Fogazzi, G.B.; Moroni, G.; Passerini, P.; D'Ambrosio, R.; Messa, P.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection

2014 | Journal article
DOI:

10.1016/j.jhep.2014.01.002

EID:

2-s2.0-84898804232
Contributors: Vermehren, J.; Aghemo, A.; Falconer, K.; Susser, S.; Lunghi, G.; Zeuzem, S.; Colombo, M.; Weiland, O.; Sarrazin, C.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review)

2014 | Journal article
DOI:

10.1007/s10620-013-2959-4

EID:

2-s2.0-84896728698
Contributors: Fabrizi, F.; Aghemo, A.; Moroni, G.; Passerini, P.; D'Ambrosio, R.; Martin, P.; Messa, P.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis

2014 | Journal article
DOI:

10.1111/jvh.12119

EID:

2-s2.0-84891833152
Contributors: Fraquelli, M.; Giunta, M.; Pozzi, R.; Rigamonti, C.; Della Valle, S.; Massironi, S.; Conti, C.B.; Aghemo, A.; Ronchi, G.; Iurlo, A. et al.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Hepatitis C genotype 3: A tough match for interferon-free regimens

2014 | Journal article
DOI:

10.1053/j.gastro.2014.02.014

EID:

2-s2.0-84896467026
Contributors: Aghemo, A.; Colombo, M.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation

2014 | Journal article
DOI:

10.1016/j.dld.2013.08.138

EID:

2-s2.0-84893642581
Contributors: Dell'Era, A.; Iannuzzi, F.; Fabris, F.M.; Fontana, P.; Reati, R.; Grillo, P.; Aghemo, A.; de Franchis, R.; Primignani, M.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Treatment of patients with dual hepatitis B and C: A step in the right direction

2014 | Journal article
DOI:

10.1136/gutjnl-2013-305115

EID:

2-s2.0-84890845195
Contributors: Aghemo, A.; Colombo, M.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF)

2014 | Journal article
DOI:

10.1016/j.dld.2013.08.243

EID:

2-s2.0-84892373565
Contributors: Coco, B.; Caraceni, P.; Aghemo, A.; Bitetto, D.; Bruno, R.; Ciancio, A.; Marzioni, M.; Petta, S.; Rendina, M.; Valenti, L.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Allelic inhibition of displacement activity: A simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms

2013 | Journal article
DOI:

10.1016/j.jviromet.2012.11.026

EID:

2-s2.0-84871421345
Contributors: Galmozzi, E.; Facchetti, F.; Degasperi, E.; Aghemo, A.; Lampertico, P.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients

2013 | Journal article
DOI:

10.1155/2013/580796

EID:

2-s2.0-84880908310
Contributors: Aghemo, A.; Degasperi, E.; Rumi, M.G.; Galmozzi, E.; Valenti, L.; De Francesco, R.; De Nicola, S.; Cheroni, C.; Grassi, E.; Colombo, M.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C

2013 | Journal article
DOI:

10.1111/apt.12406

EID:

2-s2.0-84882434831
Contributors: Aghemo, A.; Lampertico, P.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis

2013 | Journal article
DOI:

10.1016/j.dld.2012.08.009

EID:

2-s2.0-84871620064
Contributors: Iavarone, M.; Manini, M.A.; Sangiovanni, A.; Fraquelli, M.; Forzenigo, L.V.; Di Tommaso, L.; Aghemo, A.; Roncalli, M.; Ronchi, G.; Colombo, M.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier

Directly acting antivirals for the treatment of chronic hepatitis C: Unresolved topics from registration trials

2013 | Journal article
DOI:

10.1016/j.dld.2012.05.002

EID:

2-s2.0-84871615082
Contributors: Aghemo, A.; Degasperi, E.; Colombo, M.
Source: Self-asserted source
Alessio Aghemo via Scopus - Elsevier
Items per page:
Page 1 of 3
How many people are using ORCID?